Gregory H Tyson1, Patrick F McDermott1, Cong Li1, Yuansha Chen1, Daniel A Tadesse1, Sampa Mukherjee1, Sonya Bodeis-Jones1, Claudine Kabera1, Stuart A Gaines1, Guy H Loneragan2, Tom S Edrington3, Mary Torrence4, Dayna M Harhay5, Shaohua Zhao6. 1. Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, US Food and Drug Administration, Laurel, MD, USA. 2. International Center for Food Industry Excellence, Department of Animal and Food Sciences, Texas Tech University, Lubbock, TX, USA. 3. Food and Feed Safety Research Unit, Agricultural Research Service, US Department of Agriculture, College Station, TX, USA. 4. Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, MD, USA. 5. US Meat Animal Research Center, Agricultural Research Service, US Department of Agriculture, Clay Center, NE, USA. 6. Division of Animal and Food Microbiology, Office of Research, Center for Veterinary Medicine, US Food and Drug Administration, Laurel, MD, USA shaohua.zhao@fda.hhs.gov.
Abstract
OBJECTIVES: The objective of this study was to determine the effectiveness of WGS in identifying resistance genotypes of MDR Escherichia coli and whether these correlate with observed phenotypes. METHODS: Seventy-six E. coli strains were isolated from farm cattle and measured for phenotypic resistance to 15 antimicrobials with the Sensititre(®) system. Isolates with resistance to at least four antimicrobials in three classes were selected for WGS using an Illumina MiSeq. Genotypic analysis was conducted with in-house Perl scripts using BLAST analysis to identify known genes and mutations associated with clinical resistance. RESULTS: Over 30 resistance genes and a number of resistance mutations were identified among the E. coli isolates. Resistance genotypes correlated with 97.8% specificity and 99.6% sensitivity to the identified phenotypes. The majority of discordant results were attributable to the aminoglycoside streptomycin, whereas there was a perfect genotype-phenotype correlation for most antibiotic classes such as tetracyclines, quinolones and phenicols. WGS also revealed information about rare resistance mechanisms, such as structural mutations in chromosomal copies of ampC conferring third-generation cephalosporin resistance. CONCLUSIONS: WGS can provide comprehensive resistance genotypes and is capable of accurately predicting resistance phenotypes, making it a valuable tool for surveillance. Moreover, the data presented here showing the ability to accurately predict resistance suggest that WGS may be used as a screening tool in selecting anti-infective therapy, especially as costs drop and methods improve. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
OBJECTIVES: The objective of this study was to determine the effectiveness of WGS in identifying resistance genotypes of MDR Escherichia coli and whether these correlate with observed phenotypes. METHODS: Seventy-six E. coli strains were isolated from farm cattle and measured for phenotypic resistance to 15 antimicrobials with the Sensititre(®) system. Isolates with resistance to at least four antimicrobials in three classes were selected for WGS using an Illumina MiSeq. Genotypic analysis was conducted with in-house Perl scripts using BLAST analysis to identify known genes and mutations associated with clinical resistance. RESULTS: Over 30 resistance genes and a number of resistance mutations were identified among the E. coli isolates. Resistance genotypes correlated with 97.8% specificity and 99.6% sensitivity to the identified phenotypes. The majority of discordant results were attributable to the aminoglycosidestreptomycin, whereas there was a perfect genotype-phenotype correlation for most antibiotic classes such as tetracyclines, quinolones and phenicols. WGS also revealed information about rare resistance mechanisms, such as structural mutations in chromosomal copies of ampC conferring third-generation cephalosporin resistance. CONCLUSIONS: WGS can provide comprehensive resistance genotypes and is capable of accurately predicting resistance phenotypes, making it a valuable tool for surveillance. Moreover, the data presented here showing the ability to accurately predict resistance suggest that WGS may be used as a screening tool in selecting anti-infective therapy, especially as costs drop and methods improve. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Michael Feldgarden; Vyacheslav Brover; Daniel H Haft; Arjun B Prasad; Douglas J Slotta; Igor Tolstoy; Gregory H Tyson; Shaohua Zhao; Chih-Hao Hsu; Patrick F McDermott; Daniel A Tadesse; Cesar Morales; Mustafa Simmons; Glenn Tillman; Jamie Wasilenko; Jason P Folster; William Klimke Journal: Antimicrob Agents Chemother Date: 2019-10-22 Impact factor: 5.191
Authors: Gregory H Tyson; Shaohua Zhao; Cong Li; Sherry Ayers; Jonathan L Sabo; Claudia Lam; Ron A Miller; Patrick F McDermott Journal: Antimicrob Agents Chemother Date: 2017-02-23 Impact factor: 5.191
Authors: S Zhao; G H Tyson; Y Chen; C Li; S Mukherjee; S Young; C Lam; J P Folster; J M Whichard; P F McDermott Journal: Appl Environ Microbiol Date: 2015-10-30 Impact factor: 4.792
Authors: George A Jacoby; Robert A Bonomo; Patricia A Bradford; Karen Bush; Yohei Doi; Michael Feldgarden; Daniel Haft; William Klimke; Patrice Nordmann; Timothy Palzkill; Laurent Poirel; Arjun Prasad; Gian Maria Rossolini; Timothy Walsh Journal: J Antimicrob Chemother Date: 2016-06-03 Impact factor: 5.790
Authors: Carolyn Zhang; Wenchen Song; Helena R Ma; Xiao Peng; Deverick J Anderson; Vance G Fowler; Joshua T Thaden; Minfeng Xiao; Lingchong You Journal: Proc Natl Acad Sci U S A Date: 2020-08-03 Impact factor: 11.205
Authors: Scott Quainoo; Jordy P M Coolen; Sacha A F T van Hijum; Martijn A Huynen; Willem J G Melchers; Willem van Schaik; Heiman F L Wertheim Journal: Clin Microbiol Rev Date: 2017-10 Impact factor: 26.132